Effects of a combined supplementation of conjugated linoleic acid (CLA/Tonalin® SG1000T FFA) and probiotics (Vivomixx®/VSL#3) as add-on to a first-line immunotherapy in relapsing-remitting Multiple Sclerosis

Beteiligte Wissenschaftlerin:
Dr. rer. medic. Dipl.-Stat. M. Eveslage

Studienleitung:
Univ.-Prof. Dr. med. Luisa Klotz

The aim of the study is to investigate whether the combination of food supplementation with CLA and specific probiotics is a safe and effective add-on to first-line disease modifying treatment (DMT) in relapsing remitting MS (RRMS). The study is a two-arm, randomized, double-blind, placebo-controlled multicentre study in patients with relapsing-remitting multiple sclerosis (RRMS) with currently stable disease under treatment with a DMT with a mild to moderate effect on relapse rate and progression.